{"id":18346,"date":"2025-09-16T23:58:24","date_gmt":"2025-09-16T18:28:24","guid":{"rendered":"http:\/\/43.205.138.160\/?post_type=article&#038;p=18346"},"modified":"2025-09-16T23:58:24","modified_gmt":"2025-09-16T18:28:24","slug":"daily-chart-analysis-of-drreddy","status":"publish","type":"article","link":"https:\/\/signalz.pro\/article\/daily-chart-analysis-of-drreddy\/","title":{"rendered":"Daily Chart Analysis of DRREDDY"},"content":{"rendered":"<p><strong><u>Technical Chart Analysis of DRREDDY<br \/>\n<\/u><\/strong>DRREDDY is showing signs of recovery after a recent consolidation. The daily chart indicates that price has moved above its shorter-term moving averages (20\/50 EMA), which suggests that some buying interest is returning.<br \/>\nEven though the trend had been weak earlier (lower highs, lower lows), the stock managed to form a higher low recently, showing that downside momentum may be easing.<br \/>\nKey resistance lies around the <strong>\u20b91,320-\u20b91,340<\/strong> zone; sustaining above this area would be a positive sign for further upside.<br \/>\nSupport zones are forming in the <strong>\u20b91,260-\u20b91,240<\/strong> region; a fall below these could put pressure on the recovery.<br \/>\nIndicators: RSI is moderately positive, MACD has shown signs of flattening and possibly preparing for a crossover, but is not yet strongly bullish. Volume confirmation in coming sessions will be important to validate the move.<\/p>\n<p><strong><u>Fundamental View<br \/>\n<\/u><\/strong>Dr. Reddy\u2019s is a major Indian pharma company, with well-diversified operations in <strong>generics, branded drugs, biosimilars, and research pipelines<\/strong>.<strong><br \/>\n<\/strong>It has a strong global presence and multiple manufacturing\/export units, contributing to global API and finished dosage supplies.<strong><br \/>\n<\/strong>The company has been focusing on launching novel molecules, entering new therapeutic categories, and expanding its branded portfolio.<strong><br \/>\n<\/strong>Financially, Dr. Reddy\u2019s has had periods of margin pressure due to regulatory compliance, raw material cost fluctuations, and competition, but its product launches and pipeline updates offer levers for growth.<\/p>\n<p><a href=\"http:\/\/43.205.138.160\/wp-content\/uploads\/2025\/09\/Daily-Chart-Analysis-of-DRREDDY-on-16092025.pdf\">Daily Chart Analysis of DRREDDY on 16092025<\/a><\/p>\n","protected":false},"template":"","article-category":[35],"article-tags":[386,400,130,163,183,121,116,129,168,127],"class_list":["post-18346","article","type-article","status-publish","hentry","article-category-learn","article-tags-optionstrading","article-tags-technicalanalysis","article-tags-expert-analysis","article-tags-financialeducation","article-tags-investingtips","article-tags-investment-opportunities","article-tags-signalzinvestmenttips","article-tags-stock-market-tips","article-tags-stockmarkettips","article-tags-successful-investing"],"acf":[],"_links":{"self":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/article\/18346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/article"}],"about":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/types\/article"}],"wp:attachment":[{"href":"https:\/\/signalz.pro\/api\/wp\/v2\/media?parent=18346"}],"wp:term":[{"taxonomy":"article-category","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/article-category?post=18346"},{"taxonomy":"article-tags","embeddable":true,"href":"https:\/\/signalz.pro\/api\/wp\/v2\/article-tags?post=18346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}